Scotiabank analyst Sung Ji Nam maintains $Exact Sciences (EXAS.US)$ with a buy rating, and maintains the target price at $70.
According to TipRanks data, the analyst has a success rate of 50.8% and a total average return of 0.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Exact Sciences (EXAS.US)$'s main analysts recently are as follows:
The firm's assessment of Exact Sciences was adjusted following the company's announcement of Q3 results that did not meet expectations, coupled with a reduction in FY24 forecasts due to underwhelming outcomes and various challenges anticipated in Q4. The subsequent 30% post-market decline in the stock is perceived as potentially more indicative of market sentiment (crowded long) and apprehensions regarding growth prospects, with the view that there is potential for recovery from this recent downturn.
The company's recent challenges are seen as short-lived, although the recent results have been recognized as not meeting high standards.
Exact Sciences' Q3 revenue did not meet expectations, and the company has reduced its guidance for the second half of the year due to multiple factors affecting its Cologuard product. Despite this, long-range plans for 2027 remain unchanged, and it is anticipated that growth will pick up in 2025. The current valuation is perceived as having support in the low $50 range, with the recent 30% decline in stock price being viewed as excessive.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
丰业银行分析师Sung Ji Nam维持$精密科学 (EXAS.US)$买入评级，维持目标价70美元。
根据TipRanks数据显示，该分析师近一年总胜率为50.8%，总平均回报率为0.2%。
此外，综合报道，$精密科学 (EXAS.US)$近期主要分析师观点如下：
在Exact Sciences公布的第三季度业绩未达到预期之后，该公司对Exact Sciences的评估进行了调整，同时由于业绩不佳以及预计在第四季度面临的各种挑战，对24财年的预测进行了下调。该股随后盘后下跌了30％，这可能更多地表明了市场情绪（多头拥挤）和对增长前景的担忧，因为该股有可能从最近的低迷中复苏。
尽管最近的业绩被认为不符合高标准，但该公司最近的挑战被认为是短暂的。
Exact Sciences第三季度的收入未达到预期，由于影响其Cologuard产品的多种因素，该公司下调了下半年的预期。尽管如此，2027年的长期计划保持不变，预计增长将在2025年回升。目前的估值被认为在50美元的低位区间内有支撑，最近股价下跌30％被认为是过度下跌的。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
